Mirae Asset Global ETFs Holdings
TNXP icon

Mirae Asset Global ETFs Holdings’s Tonix Pharmaceuticals TNXP Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.8K Buy
6,383
+995
+18% +$15.3K ﹤0.01% 2724
2025
Q4 		$84.2K Buy
5,388
+1,275
+31% +$23.5K ﹤0.01% 2748
2025
Q3 		$99.4K Sell
4,113
-30
-0.7% -$1.11K ﹤0.01% 2664
2025
Q2 		$149K Buy
+4,143
New +$109K ﹤0.01% 2419

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TNXP Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Tonix Pharmaceuticals (TNXP) stake by 18% in Q1 2026, buying an estimated $15.3K and bringing the position to 6,383 shares worth $87.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2724.

Mirae Asset Global ETFs Holdings first reported a position in TNXP in Q2 2025 and has held it in 4 quarters since. The position peaked at $149K in Q2 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 6,383 shares of Tonix Pharmaceuticals worth $87.8K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 995 Tonix Pharmaceuticals shares in Q1 2026, an estimated $15.3K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2724 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Mirae Asset Global ETFs Holdings's Tonix Pharmaceuticals position peaked at $149K in Q2 2025.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.